Serum homocysteine and folate but not vitamin B12 are predictors of CHD mortality in older adults

European Journal of Preventive Cardiology

Volumn 19, Issue 6, 2012, Pages 1420-1429

  Gopinath, Bamini ^a   Flood, Victoria M ^b   Rochtchina, Elena ^a   Thiagalingam, Aravinda ^a   Mitchell, Paul ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

All cause mortality; Blue Mountains Eye Study; coronary heart disease; folate; homocysteine; incidence; mortality; older adults; vitamin B12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR MORTALITY; CAUSAL ATTRIBUTION; FEMALE; FOLIC ACID DEFICIENCY; HUMAN; HYPERHOMOCYSTEINEMIA; ISCHEMIC HEART DISEASE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE;

AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CORONARY DISEASE; DOWN-REGULATION; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEW SOUTH WALES; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; UP-REGULATION; VITAMIN B 12;

EID: 84873912541     PISSN: 20474873     EISSN: None     Source Type: Journal    
DOI: 10.1177/1741826711424568     Document Type: Article

References (43)

1. Truelsen T, Mahonen M, Tolonen H, Asplund K, Bonita R, Vanuzzo D. Trends in stroke and coronary heart disease in the WHO MONICA Project. Stroke. 2003 ; 34 (6). 1346-1352
2. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998 ; 97 (18). 1837-1847
3. Smith SC. Current and future directions of cardiovascular risk prediction. Am J Cardiol. 2006 ; 97 (2A). 28A - 32A
4. Humphrey LL, Fu R, Rogers K, Freeman M, Helfand M. Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis. Mayo Clin Proc. 2008 ; 83 (11). 1203-1212
5. Daly C, Fitzgerald AP, O'Callaghan P, Collins P, Cooney MT, Graham IM. Homocysteine increases the risk associated with hyperlipidaemia. Eur J Cardiovasc Prev Rehabil. 2009 ; 16 (2). 150-155
6. Cummings DM, King DE, Mainous AG, Geesey ME. Combining serum biomarkers: the association of C-reactive protein, insulin sensitivity, and homocysteine with cardiovascular disease history in the general US population. Eur J Cardiovasc Prev Rehabil. 2006 ; 13 (2). 180-185
7. Marti-Carvajal AJ, Sola I, Lathyris D, Salanti G. Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev. 2009 ;: (4): CD006612.
8. Christen WG, Ajani UA, Glynn RJ, Hennekens CH. Blood levels of homocysteine and increased risks of cardiovascular disease: causal or casual?. Arch Intern Med. 2000 ; 160 (3). 422-434
9. Dangour AD, Breeze E, Clarke R, Shetty PS, Uauy R, Fletcher AE. Plasma homocysteine, but not folate or vitamin B-12, predicts mortality in older people in the United Kingdom. J Nutr. 2008 ; 138 (6). 1121-1128
10. Vollset SE, Refsum H, Tverdal A, Nygard O, Nordrehaug JE, Tell GS, et al. Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine Study. Am J Clin Nutr. 2001 ; 74 (1). 130-136
11. de Ruijter W, Westendorp RG, Assendelft WJ, den Elzen WP, de Craen AJ, et al. Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ. 2009 ; 338: a3083 - a3083
12. Wald NJ, Watt HC, Law MR, Weir DG, McPartlin J, Scott JM. Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention. Arch Intern Med. 1998 ; 158 (8). 862-867
13. Bots ML, Launer LJ, Lindemans J, Hoes AW, Hofman A, Witteman JC, et al. Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study. Arch Intern Med. 1999 ; 159 (1). 38-44
14. Ridker PM, Manson JE, Buring JE, Shih J, Matias M, Hennekens CH. Homocysteine and risk of cardiovascular disease among postmenopausal women. JAMA. 1999 ; 281 (19). 1817-1821
15. Giles WH, Croft JB, Greenlund KJ, Ford ES, Kittner SJ. Total homocyst(e)ine concentration and the likelihood of nonfatal stroke: results from the third national health and nutrition examination survey, 1988-1994. Stroke. 1998 ; 29 (12). 2473-2477
16. Ubbink JB, Fehily AM, Pickering J, Elwood PC, Vermaak WJ. Homocysteine and ischaemic heart disease in the Caerphilly cohort. Atherosclerosis. 1998 ; 140 (2). 349-356
17. Folsom AR, Nieto FJ, McGovern PG, Tsai MY, Malinow MR, Eckfeldt JH, et al. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 1998 ; 98 (3). 204-210
18. Alfthan G, Pekkanen J, Jauhiainen M, Pitkaniemi J, Karvonen M, Tuomilehto J, et al. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis. 1994 ; 106 (1). 9-19
19. Ford ES, Byers TE, Giles WH. Serum folate and chronic disease risk: findings from a cohort of United States adults. Int J Epidemiol. 1998 ; 27 (4). 592-598
20. 12 deficiency: the long-term effects in cardiovascular disease. Cardiology. 2007 ; 107 (1). 57-62
21. Bates CJ, Mansoor MA, Pentieva KD, Hamer M, Mishra GD. Biochemical risk indices, including plasma homocysteine, that prospectively predict mortality in older British people: the National Diet and Nutrition Survey of People Aged 65 Years and Over. Br J Nutr. 2010 ; 104 (6). 1-7
22. Attebo K, Mitchell P, Smith W. Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study. Ophthalmology. 1996 ; 103 (3). 357-364
23. World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21(11): 1983-1992.
24. Selhub J, Jacques PF, Rosenberg IH, Rogers G, Bowman BA, Gunter EW, et al. Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991-1994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med. 1999 ; 131 (5). 331-339 [see comments]
25. Gibson R Principles of nutritional assessment. 1 st edn. New York: Oxford University Press, 1990. New York: Oxford University Press.
26. Manual of the international statistical classification of disease, injuries and causes of death. Geneva: World Health Organization ; 1977 :
27. International statistical classification of diseases and related health problems. 10th revision [ICD-10]. Geneva: World Health Organization ; 1992 :
28. Wang JJ, Liew G, Wong TY, Smith W, Klein R, Leeder S, et al. Retinal vascular calibre and the risk of coronary heart disease-related death. Heart. 2006 ; 92 (11). 1583-1587
29. Magliano D, Liew D, Pater H, Kirby A, Hunt D, Simes J, et al. Accuracy of the Australian National Death Index: comparison with adjudicated fatal outcomes among Australian participants in the Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) study. Aust N Z J Public Health. 2003 ; 27 (6). 649-653
30. Refsum H, Nurk E, Smith AD, Ueland PM, Gjesdal CG, Bjelland I, et al. The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease. J Nutr. 2006 ; 136 (6 Suppl). 1731S - 1740S
31. Nurk E, Tell GS, Vollset SE, Nygard O, Refsum H, Nilsen RM, et al. Changes in lifestyle and plasma total homocysteine: the Hordaland Homocysteine Study. Am J Clin Nutr. 2004 ; 79 (5). 812-819
32. 12 and folate biomarkers. International Society of Behavioral Nutrition and Physical Activity (ISBNPA) 2011 Annual Meeting. 2011.
33. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 1993 ; 270 (22). 2693-2698
34. meta-analysis of randomised trials. Homocysteine Lowering Trialists' Collaboration. BMJ. 1998 ; 316 (7135). 894-898
35. Hung J, Beilby JP, Knuiman MW, Divitini M. Folate and vitamin B-12 and risk of fatal cardiovascular disease: cohort study from Busselton, Western Australia. BMJ. 2003 ; 326 (7381). 131-131
36. Anderson JL, Jensen KR, Carlquist JF, Bair TL, Horne BD, Muhlestein JB. Effect of folic acid fortification of food on homocysteine-related mortality. Am J Med. 2004 ; 116 (3). 158-164
37. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med. 1998 ; 338 (15). 1042-1050
38. 12, and retinal vascular caliber. Am J Ophthalmol. 2009 ; 148 (6). 902-909
39. Bostom AG, Silbershatz H, Rosenberg IH, Selhub J, D'Agostino RB, Wolf PA, et al. Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Intern Med. 1999 ; 159 (10). 1077-1080
40. Sacco RL, Anand K, Lee HS, Boden-Albala B, Stabler S, Allen R, et al. Homocysteine and the risk of ischemic stroke in a triethnic cohort: the NOrthern MAnhattan Study. Stroke. 2004 ; 35 (10). 2263-2269
41. Stehouwer CD, Weijenberg MP, van den Berg M, Jakobs C, Feskens EJ, Kromhout D. Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men: a 10-year follow-up. Arterioscler Thromb Vasc Biol. 1998 ; 18 (12). 1895-1901
42. Gonzalez S, Huerta JM, Fernandez S, Patterson AM, Lasheras C. Homocysteine increases the risk of mortality in elderly individuals. Br J Nutr. 2007 ; 97 (6). 1138-1143
43. Marniemi J, Jarvisalo J, Toikka T, Raiha I, Ahotupa M, Sourander L. Blood vitamins, mineral elements and inflammation markers as risk factors of vascular and non-vascular disease mortality in an elderly population. Int J Epidemiol. 1998 ; 27 (5). 799-807